Antineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantCombined Modality TherapyAnti-Bacterial AgentsAntineoplastic AgentsAntibiotic ProphylaxisCisplatinTreatment OutcomeDoxorubicinCyclophosphamideAntibiotics, AntineoplasticNeoadjuvant TherapyMicrobial Sensitivity TestsDisease-Free SurvivalEtoposideBreast NeoplasmsDrug Administration ScheduleSurvival AnalysisNeoplasm StagingPrognosisSurvival RateDrug Resistance, BacterialLung NeoplasmsDrug Resistance, MicrobialMethotrexateStreptomycesAminoglycosidesCarboplatinPaclitaxelVinblastineInduction ChemotherapyTaxoidsNeoplasm Recurrence, LocalTime FactorsBacterial InfectionsBleomycinIfosfamideAnthracyclinesDrug Resistance, NeoplasmNeoplasmsBacteriaDeoxycytidineAntimetabolites, AntineoplasticOrganoplatinum CompoundsProspective StudiesFollow-Up StudiesNeutropeniaGentamicinsDrug UtilizationAntineoplastic Agents, AlkylatingCytarabineChemotherapy, Cancer, Regional PerfusionSalvage Therapybeta-LactamsCarcinoma, Non-Small-Cell LungPenicillinsOvarian NeoplasmsNeoplasm MetastasisVomitingTransplantation, AutologousTesticular NeoplasmsLymphoma, Non-HodgkinClinical Trials as TopicAdenocarcinomaNauseaAntineoplastic Agents, PhytogenicFermentationHodgkin DiseaseErythromycinRadiotherapy, AdjuvantTetracyclineAmpicillinEscherichia coliDose-Response Relationship, DrugDrug TherapyMacrolidesColorectal NeoplasmsStaphylococcus aureusRadiotherapyDrug Resistance, Multiple, BacterialInfusions, IntravenousGranulocyte Colony-Stimulating FactorRecurrenceCephalosporinsAnti-Infective AgentsStreptomycinDacarbazineCarmustineKaplan-Meier EstimateNeoplasms, Germ Cell and EmbryonalMitomycinBacterial ProteinsRandomized Controlled Trials as TopicKanamycinLomustineLeukopeniaCamptothecinGram-Positive BacteriaBrain NeoplasmsCiprofloxacin